Exosens unifies all its products under one brand
PRESS RELEASE
MÉRIGNAC, FRANCE - 13 MAY 2026
- Exosens is gradually unifying all its brands under a single Exosens brand, in order to enhance the clarity of its offering and the visibility of its activities.
- This evolution follows the Group's growth since its IPO, which has been marked by a significant increase in the visibility and awareness of the Exosens brand.
Exosens (EXENS, FR001400Q9V2), a high-tech company focused on providing mission and performance critical amplification, detection and imaging technologies, today announces it is bringing together all its brands under the "Exosens" name.
This marks an important step in the Group's development, and is in line with the trajectory it has followed since its IPO. Almost two years after this important milestone, Exosens has actively strengthened its visibility in its markets and continued to implement its growth strategy, both organically and through targeted acquisitions.
Over this period, Exosens has integrated leading technological expertise and built up a unique portfolio of solutions covering the entire amplification, detection and imaging spectrum. This has enabled the Group to significantly strengthen its positions in critical markets such as Defense, Nuclear, Life Sciences and Industrial Control, while integrating complementary teams, technologies and portfolios.
As part of this move, products from the group Exosens currently marketed under different brands, such as Photonis, Xenics, El-Mul or Telops and more recently Noxant, Phasics and Emberion will gradually come under the Exosens brand. The unification of these brands under the Exosens name is a natural step in the integration of the Group. This will provide customers and partners with a simpler, more coherent and clearer understanding of the Group's offering, while enabling all products to fully benefit from the strength, reputation and credibility of the Exosens name on an international scale.
"This marks a new phase in Exosens’ growth. By bringing our products together under a single brand, we are affirming the consistency of our offering and strengthening the Group's visibility in all our markets. This unification also reflects our desire to capitalize on the collective strength of our teams and technologies to continue to innovate and support our customers in their most demanding missions", says Paul Ryckaert, Chief Strategy Officer at Exosens.
Investor Relations:
Laurent Sfaxi, l.sfaxi@exosens.com
Media Relations:
Brunswick Group - exosens@brunswickgroup.com
Laetitia Quignon, + 33 6 83 17 89 13
Nicolas Buffenoir, + 33 6 31 89 36 78